Fulgent Genetics Inc.
FLGT | NASDAQ
$21.54
-$0.15 (-0.69%)
At close: Sep 21, 2026, 4:00 PM ET
$21.54
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -13.34 | -13.10 | -5.13 | 6.26 | 5.87 | 5.52 |
PEG Ratio | -0.34 | 0.17 | 0.02 | -0.09 | 0.07 | 0 |
PS Ratio | 2.51 | 1.97 | 2.98 | 1.45 | 2.98 | 2.80 |
PB Ratio | 0.73 | 0.49 | 0.76 | 0.71 | 2.55 | 2.08 |
P/FCF Ratio | -6.51 | -29 | 179.54 | 3.82 | 5.75 | 11.36 |
P/OCF Ratio | -7.95 | 26.52 | 31.89 | 3.54 | 5.49 | 8.41 |
OCF/S Ratio | -31.50 | 7.43 | 9.34 | 40.96 | 54.26 | 33.35 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.03 |
Quick Ratio | 6.35 | 4.74 | 6.88 | 7.08 | 5.70 | 3.90 |
Current Ratio | 6.48 | 4.85 | 6.96 | 7.13 | 5.81 | 4.02 |
Asset Turnover | 0.27 | 0.23 | 0.23 | 0.45 | 0.78 | 0.60 |
Interest Coverage | -1.21K | -434.81 | -400.67 | 176.24 | n/a | n/a |
Return on Equity | -5.44% | -3.77% | -14.77% | 11.32% | 43.79% | 37.64% |
Return on Assets | -4.99% | -3.50% | -13.59% | 10.35% | 39.68% | 30.60% |
Return on Invested Capital | -7.09% | -5.43% | -16.75% | 10.39% | 42.06% | 37.02% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 40.56% | 37.82% | 36.12% | 59.28% | 78.29% | 78.70% |
Net Profit Margin | -18.75% | -15.07% | -58.03% | 23.17% | 51.12% | 50.82% |
Pretax Profit Margin | -21.70% | -18.33% | -60.19% | 29.73% | 68.61% | 68.02% |
Operating Profit Margin | -28.23% | -26.08% | -67.61% | 28.84% | 68.10% | 68.80% |
FCF Margin | -38.49% | -6.79% | 1.66% | 37.93% | 51.86% | 24.69% |
EBITDA Margin | -14.20% | -9.47% | -50.98% | 35.17% | 69.72% | 69.51% |
Add to Watchlist
Select watchlists to add or remove FLGT